본문 바로가기
KERD
논문KCI 등재

Procalcitonin as a biomarker of infectious diseases

1

조회

0

다운로드

6

인용

0

참고문헌

키워드

주제분류내과학

초록

Traditional biomarkers, including C-reactive protein, leukocytes, erythrocyte sedimentation rate, and clinical signs and symptoms, are not sufficiently sensitive or specific enough to guide treatment decisions in infectious febrile diseases. Procalcitonin (PCT) is synthesized by a large number of tissues and organs in response to invasion by pathogenic bacteria, fungi, and some parasites. A growing body of evidence supports the use of PCT as a marker to improve the diagnosis of bacterial infections and to guide antibiotic therapy. Clinically, PCT levels may help guide the need for empirical antibiotic therapy, source control for infections,and duration of antibiotic therapy. The aim of this review is to summarize the current evidence for PCT in different infections and clinical settings, and to discuss the reliability of this marker in order to provide physicians with an overview of the potential for PCT to guide antibiotic therapy.

Abstract

Traditional biomarkers, including C-reactive protein, leukocytes, erythrocyte sedimentation rate, and clinical signs and symptoms, are not sufficiently sensitive or specific enough to guide treatment decisions in infectious febrile diseases. Procalcitonin (PCT) is synthesized by a large number of tissues and organs in response to invasion by pathogenic bacteria, fungi, and some parasites. A growing body of evidence supports the use of PCT as a marker to improve the diagnosis of bacterial infections and to guide antibiotic therapy. Clinically, PCT levels may help guide the need for empirical antibiotic therapy, source control for infections,and duration of antibiotic therapy. The aim of this review is to summarize the current evidence for PCT in different infections and clinical settings, and to discuss the reliability of this marker in order to provide physicians with an overview of the potential for PCT to guide antibiotic therapy.

참고문헌 (39)

  1. Schuetz P, "Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future", BMC Med, 9, pp.107~ (2011)
  2. Muller B, "Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia", BMC Infect Dis, 7, pp.10~ (2007)
  3. Chung TP, "Functional genomics of critical illness and injury", Crit Care Med, 30(1), pp.51~57 (2002)
  4. Bagshaw SM, "Early diagnosis of acute kidney injury", Curr Opin Crit Care, 13, pp.638~644 (2007)
  5. Schuetz P, "Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis", Clin Infect Dis, 55, pp.651~662 (2012)
  6. Matthaiou DK, "Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients", Intensive Care Med, 38, pp.940~949 (2012)
  7. Gilbert DN, "Use of plasma procalcitonin levels as an adjunct to clinical microbiology", J Clin Microbiol, 48, pp.2325~2329 (2010)
  8. Schuetz P, "Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections: hope for hype?", Swiss Med Wkly, 139, pp.318~326 (2009)
  9. Linscheid P, "In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue", Endocrinology, 144, pp.5578~5584 (2003)
  10. Morgenthaler NG, "Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA", Clin Lab, 48, pp.263~270 (2002)
  11. Christ-Crain M, "Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators", Eur Respir J, 30, pp.556~573 (2007)
  12. Pfaff lin A, "Inf lammation markers in point-of-care testing (POCT)", Anal Bioanal Chem, 393, pp.1473~1480 (2009)
  13. Brunkhorst FM, "Kinetics of procalcitonin in iatrogenic sepsis", Intensive Care Med, 24, pp.888~889 (1998)
  14. Limper M, "The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from noninfectious fever", J Infect, 60, pp.409~416 (2010)
  15. Muller B, "Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit", Crit Care Med, 28, pp.977~983 (2000)
  16. Harbarth S, "Diagnostic value of procalcitonin, interleukin-6, and interleukin- 8 in critically ill patients admitted with suspected sepsis", Am J Respir Crit Care Med, 164, pp.396~402 (2001)
  17. Aabenhus R, "Procalcitonin-guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?", Prim Care Respir J, 20, pp.360~367 (2011)
  18. Schuetz P, "Procalcitonin for guidance of antibiotic therapy", Expert Rev Anti Infect Ther, 8, pp.575~587 (2010)
  19. Manian FA., "Use of procalcitonin to guide duration of antimicrobial therapy in intensive care units: proceed with caution", Clin Infect Dis, 54, pp.578~ (2012)
  20. Tang BM, "Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis", Lancet Infect Dis, 7, pp.210~217 (2007)
  21. Uzzan B, "Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis", Crit Care Med, 34, pp.1996~2003 (2006)
  22. Meisner M, "Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS", Crit Care, 3, pp.45~50 (1999)
  23. Reinhart K, "Biomarkers in the critically ill patient: procalcitonin", Crit Care Clin, 27, pp.253~263 (2011)
  24. Reinhart K, "New approaches to sepsis: molecular diagnostics and biomarkers", Clin Microbiol Rev, 25, pp.609~634 (2012)
  25. Li H, "Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections", Antimicrob Agents Chemother, 55, pp.5900~5906 (2011)
  26. Schuetz P, "Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial", JAMA, 302, pp.1059~1066 (2009)
  27. Gac AC, "Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia", Leuk Res, 35, pp.1294~1296 (2011)
  28. Perrakis A, "Procalcitonin in the setting of complicated postoperative course after liver transplantation", Transplant Proc, 42, pp.4187~4190 (2010)
  29. Sakr Y, "The role of procalcitonin in febrile neutropenic patients: review of the literature", Infection, 36, pp.396~407 (2008)
  30. Jereb M, "Predictive value of serum and cerebrospinal f luid procalcitonin levels for the diagnosis of bacterial meningitis", Infection, 29, pp.209~212 (2001)
  31. Schwarz S, "Serum procalcitonin levels in bacterial and abacterial meningitis", Crit Care Med, 28, pp.1828~1832 (2000)
  32. Bouadma L, "Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial", Lancet, 375, pp.463~474 (2010)
  33. Kopterides P, "Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials", Crit Care Med, 38, pp.2229~2241 (2010)
  34. Stolz D, "Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study", Eur Respir J, 34, pp.1364~1375 (2009)
  35. Nobre V, "Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial", Am J Respir Crit Care Med, 177, pp.498~505 (2008)
  36. Riedel S., "Procalcitonin and antibiotic therapy: can we improve antimicrobial stewardship in the intensive care setting?", Crit Care Med, 40, pp.2499~2500 (2012)
  37. Kim HA, "C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8", A9 and procalcitonin, 2012, pp.39, 728~734
  38. Hunziker S, "The value of serum procalcitonin level for differentiation of infectious from noninfectious causes of fever after orthopaedic surgery", J Bone Joint Surg Am, 92, pp.138~148 (2010)
  39. Becker KL, "Procalcitonin assay in systemic inf lammation, infection, and sepsis: clinical utility and limitations", Crit Care Med, 36, pp.941~952 (2008)

관련 논문AI추천

이 간행물의 다른 논문 (11건)